Identification of 30 kDa protein for Ca2+ releasing action of myotoxin a with a mechanism common to DIDS in skeletal muscle sarcoplasmic reticulum  by Hirata, Yutaka et al.
Identi¢cation of 30 kDa protein for Ca2 releasing action of
myotoxin a with a mechanism common to DIDS in skeletal muscle
sarcoplasmic reticulum
Yutaka Hirata, Norimichi Nakahata *, Masamichi Ohkura, Yasushi Ohizumi
Department of Pharmaceutical Molecular Biology, Faculty of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-Ku,
Sendai 980-8578, Japan
Received 9 March 1999; received in revised form 7 June 1999; accepted 11 June 1999
Abstract
The molecular mechanism of Ca2 release by myotoxin a (MTYX), a polypeptide toxin isolated from the venom of prairie
rattlesnakes (Crotalus viridis viridis), was investigated in the heavy fraction of sarcoplasmic reticulum (HSR) of rabbit
skeletal muscles. [125I]MYTX bound to four HSR proteins (106, 74, 53 and 30 kDa) on polyvinylidene difluoride (PVDF)
membrane. DIDS, 4,4P-diisothiocyanatostilbene-2,2P-disulfonic acid, bound predominantly to 30 kDa protein on the PVDF
membrane, the molecular weight of which was similar to one of the MYTX binding proteins. The maximum 45Ca2 release
induced by caffeine (30 mM) was further increased in the presence of MYTX (10 WM) or DIDS (30 WM), whereas that
induced by DIDS (30 WM) was not affected by MYTX (10 WM). MYTX inhibited [3H]DIDS binding to HSR in a
concentration-dependent manner. Furthermore, [125I]MYTX binding to 30 kDa protein was inhibited by DIDS in a
concentration-dependent manner. These results suggest that MYTX and DIDS release Ca2 from HSR in a common
mechanism. The 30 kDa protein may be a target protein for the Ca2 releasing action of MYTX and DIDS. ß 1999
Elsevier Science B.V. All rights reserved.
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1. Introduction
In excitation-contraction coupling of skeletal
muscle, depolarization of the transverse tubule leads
to Ca2 release from the sarcoplasmic reticulum
(SR), resulting in muscle contraction [1^3]. Ryano-
dine receptor (RyR) in SR is responsible for the Ca2
release from the Ca2 store as a Ca2 release channel
[4^6]. Recently, it has been reported that RyR forms
a complex with some intrinsic proteins such as calse-
questrin [7^9], triadin [10], junctin [11,12], 30 kDa
protein [13^15] and mitsugumin29 [16,17] in the
SR. However, the detailed mechanism of the regula-
tion of RyR by these intrinsic proteins remains to be
solved.
Myotoxin a (MYTX), which was isolated from
prairie rattlesnake (Crotalus viridis viridis) venom
[18] as a basic polypeptide, is composed of 42 amino
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acid residues, including three disul¢de bonds [19].
Intramuscular injection of MYTX caused immediate
and sustained local skeletal muscle contracture, fol-
lowed by vacuolation of the SR after 12^24 h and
degeneration of the myo¢brils without damage of the
membranes of sarcolemma and SR after 48^72 h
[18,20,21]. Recently, we found that MYTX strongly
induced Ca2 release from the heavy fraction of SR
(HSR) containing RyR [22]. Although MYTX-in-
duced Ca2 release from HSR was completely inhib-
ited by Mg2 and ruthenium red, Ca2 channel
blockers [22], [125I]MYTX binding to HSR was not
a¡ected by these blockers [23]. Since [125I]MYTX did
not bind to the puri¢ed RyR [24] but the MYTX-
induced Ca2 release was abolished by pretreatment
with ryanodine [25], MYTX is assumed to bind to
important regulatory proteins in Ca2 release, which
are distinct from the RyR.
The research of MYTX binding proteins in HSR
revealed that MYTX bound to Ca2 pump [26,27].
However, Yudkowsky et al. [28] suggested that a
dominant action of MYTX was not Ca2 uptake in
HSR. In solubilized HSR, MYTX bound directly to
calsequestrin (CS) [24], which is essential for Ca2
release as a source of Ca2. However, it is not as-
sumed that CS is a target protein for the Ca2 releas-
ing action of MYTX, because CS is not a transmem-
brane protein and is localized in the lumen of the
interior junctional SR [9]. It has been reported that
peroxidase-conjugated MYTX attached to the face
of the HSR membrane [29]. Thus, it is important
to examine the target proteins for MYTX to cause
Ca2 release from HSR except Ca2 pump or CS.
Recently, 30 kDa CS binding protein, which regu-
lates Ca2 release from skeletal SR, has been shown
to be identical to the ADP/ATP translocase found in
mitochondria [15].
DIDS, a stilbene derivative known as an anion
channel blocker [30], was shown to modulate RyR
[14,31]. It is reported that [3H]DIDS binding protein
is not the Ca2 release channel but the 30 kDa pro-
tein in the junctional face membrane in SR [14].
However, the properties of DIDS-induced 45Ca2
from HSR remain unknown.
To characterize the molecular mechanism of
MTYX-induced Ca2 release from HSR, we com-
pared the properties of MYTX and DIDS in Ca2
release.
2. Materials and methods
2.1. Materials
MYTX was puri¢ed from crude prairie rattlesnake
venom as described previously [32]. [125I]MYTX was
prepared by the method of chloramine-T [24]. The
materials used in this work were purchased from the
sources indicated: ryanodine (S.B. Penick, New
York, NY), procaine hydrochloride and DIDS (Sig-
ma, St. Louis, MO), Fluo-3 (Dojindo Laboratories,
Kumamoto, Japan), ca¡eine and ruthenium red
(Wako Pure Chemical Industries, Osaka, Japan),
[3H]DIDS (185 GBq/mmol) (Amersham Life Science,
Tokyo, Japan), Enlightening, 45CaCl2 (25.9 kBq/
pmol) and Na125I (95.3 kBq/pmol) (DuPont New
England Nuclear, Boston, MA). All other chemicals
were of analytical grade.
2.2. Preparation of HSR
HSR enriched in Ca2 release activity was pre-
pared from rabbit skeletal muscle [33] with a minor
modi¢cation. White muscle was homogenized 4 times
in 5 vols. of 5 mM Tris-maleate (pH 7.0) for 30 s
with 30 s intervals. The homogenate was centrifuged
at 5000Ug for 15 min. The supernatant was ¢ltered
through cheesecloth, and the ¢ltrate was centrifuged
again at 12 000Ug for 30 min. The pellets were re-
suspended in a solution containing 90 mM KCl and
5 mM Tris-maleate (pH 7.0), 76.8 WM aprotinin and
0.83 WM benzamidine (bu¡er A), and centrifuged at
70 000Ug for 40 min. The obtained HSR was stored
in bu¡er A containing 0.3 M sucrose at 380‡C until
use. The protein concentration was determined by
the dye binding method [34] with BSA as a standard.
2.3. Analysis of [125I]MYTX and [3H]DIDS binding
proteins on PVDF membrane
SDS-PAGE was conducted by the method de-
scribed by Laemmli [35]. After HSR proteins (50
Wg) were separated on 12% SDS-PAGE, they were
transferred to PVDF membranes. The membranes
were blocked by incubation with bu¡er B containing
1% BSA for 60 min and were washed 3 times with
bu¡er B for 5 min. Then, they were incubated with
[125I]MYTX (0.3 WM) or [3H]DIDS (3 WM) for 60
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min at 0‡C. After incubation with radioactive mate-
rials, blots were washed 3 times for 5 s in ice-cold
bu¡er C. Analysis of [125I]MYTX binding to HSR
proteins was performed using an image analyzer
(Molecular Imager GS-363, Bio-Rad). Analysis of
[3H]DIDS binding to HSR proteins was performed
by exposure to ¢lm after enhancement using Enlight-
ening (NEN Research Products).
2.4. Measurement of 45Ca2+ release
The 45Ca2 release from HSR passively preloaded
with 45Ca2 was measured at 0‡C as described pre-
viously [22]. After 12 h preincubation of HSR (20
mg/ml) at 0‡C in a solution containing 5 mM
45CaCl2, 90 mM KCl and 5 mM Tris-maleate (pH
7.0), HSR (5 Wl) was diluted with 500 Wl of an ice-
cold reaction medium containing 500 WM CaCl2 with
various concentrations of EGTA, 90 mM KCl and
50 mM MOPS-Tris (pH 7.0) in the presence or ab-
sence of the test substance. For measurement of the
amount of 45Ca2 in HSR at time 0, HSR was di-
luted with the reaction medium containing 5 mM
LaCl3. At an appropriate time, 5 mM LaCl3 was
added to terminate the reaction. The reaction mix-
ture was then ¢ltered though Millipore ¢lters
(HAWP type, 0.45 WM pore size, Nihon Millipore,
Japan) and washed with 5 ml of an ice-cold solution
containing 5 mM LaCl3, 90 mM KCl, 5 mM MgCl2
and 50 mM MOPS-Tris (pH 7.0). The amount of
45Ca2 remaining in HSR was measured by counting
the radioactivity on the washed ¢lters.
2.5. Measurement of extravesicular free Ca2+
concentration
The change in the extravesicular free Ca2 concen-
tration was monitored by the intensity of Fluo-3 £u-
orescence at 30‡C. The assay mixture (¢nal volume,
0.8 ml) contained 3 WM Fluo-3, 50 WM CaCl2, 90
mM KCl, 0.5 mM MgCl2, 50 mM MOPS-Tris (pH
7.0), 0.75 mg/ml HSR, 5 mM creatine phosphate, 0.1
mg/ml creatine kinase and 0.5 mM ATP. The reac-
tion of Ca2 uptake was started by a simultaneous
addition of ATP and creatine kinase. The change in
530 nm £uorescence of Fluo-3 at an excitation wave-
length of 488 nm was measured by a £uorescence
spectrophotometer (Hitachi F-2000).
2.6. [3H]DIDS binding assay
[3H]DIDS binding was examined as follows. HSR
(100 Wg/ml) was incubated with various concentra-
tions (0.1^100 WM) of [3H]DIDS in the 90 mM
KCl, CaCl2 equivalent to 100 nM free Ca2 and 50
mM MOPS-Tris (pH 7.4) (bu¡er B) in a ¢nal volume
of 200 Wl. After incubation at 0‡C for 1 h, ice-cold 50
mM MOPS-Tris (pH 7.4) (bu¡er C) in a volume of
2.5 ml was added to each tube and the reaction mix-
ture was immediately ¢ltered under reduced pressure
through a Whatman GF/C glass ¢ber ¢lter which
was then washed twice with ice-cold bu¡er C (2.5
ml). Nonspeci¢c binding was determined in the pres-
ence of 100 WM unlabeled DIDS.
2.7. Data analysis
The data were expressed as means þ S.E.M. The
statistical di¡erence of the values was determined
by Student’s t-test.
3. Results
3.1. Identi¢cation of the skeletal muscle HSR proteins
bound to [125I]MYTX and [3H]DIDS
In order to identify the proteins bound to
[125I]MYTX, HSR proteins were separated by SDS-
PAGE, transferred to PVDF membrane, and incu-
bated with [125I]MYTX. [125I]MYTX bound to four
proteins (106, 74, 53 and 30 kDa) after transferring
to PVDF membrane, although many proteins were
identi¢ed by Coomassie staining (Fig. 1A,B). Two
proteins were assumed to be Ca2 pump [26,27]
and CS [24], which had been previously shown as
proteins associated with MYTX. The other two
[125I]MYTX binding proteins (30 and 74 kDa) have
not been identi¢ed. On the other hand, [3H]DIDS
markedly bound to 30 kDa protein on PVDF mem-
brane after SDS-PAGE. The molecular mass (30
kDa) of the protein was similar to that of a
[125I]MYTX binding protein (Fig. 1C).
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3.2. Ca2+ release induced by MYTX, DIDS and
ca¡eine from HSR
Since the properties of DIDS-induced Ca2 release
from HSR remain unknown, we compared the prop-
erties of Ca2 release induced by MYTX, DIDS and ca¡eine. Fig. 2 shows the time course of the decrease
in 45Ca2 content in HSR after the addition of
MYTX, DIDS or ca¡eine at pCa 7. DIDS (10 WM)
caused 45Ca2 release from HSR to a similar extent
as MYTX (1 WM) and ca¡eine (1 mM). Fig. 3 shows
the concentration-response curves for DIDS, MYTX
and ca¡eine in 45Ca2 release from HSR at pCa 7.
DIDS markedly accelerated 45Ca2 release in a con-
centration-dependent manner with an EC50 value of
approx. 8 WM. The EC50 values of MYTX and caf-
feine were approx. 0.5 WM and 2 mM, respectively.
Thus, DIDS is 250 times more potent than ca¡eine
and 16 times less potent than MYTX. The maximal
45Ca2 release induced by DIDS was slightly larger
than that induced by MYTX or ca¡eine. In a range
of pCa from 3 to 8, the concentration-response curve
for Ca2 was shifted upward by DIDS or MYTX,
whereas it was shifted to the left by ca¡eine (Fig. 4).
3.3. Characteristics of DIDS-induced Ca2+ release
from HSR
In order to examine the characteristics of DIDS-
Fig. 2. Stimulatory e¡ects of MYTX, DIDS and ca¡eine on
45Ca2 release from HSR. The 45Ca2 content in the HSR
vesicles was measured after drug treatment. The initial content
of 45Ca2 in HSR was 31.24 þ 0.98 nmol mg. Free Ca2 con-
centration was maintained to be 100 nM with Ca2-EGTA
bu¡er. a, control ; F, 1 WM MYTX; b, 10 WM DIDS; E, 1 mM
ca¡eine. Values are means þ S.E.M. (n = 3).
Fig. 1. Identi¢cation of the binding proteins to [125I]MYTX
and [3H]DIDS. HSR proteins (50 Wg) were separated on 12%
SDS-PAGE and transferred to PVDF membrane. (A) Coomas-
sie-stained HSR proteins on PVDF membrane. The PVDF
membrane was incubated with [125I]MYTX (B, 0.3 WM) or
[3H]DIDS (C, 3 WM) for 1 h at 0‡C after blocking with 1%
BSA. Bands: 2, CS; 4, Ca2 pump; 1 and 3, unknown pro-
teins.
Fig. 3. Concentration-dependent acceleration of 45Ca2 release
from HSR by MYTX, DIDS and ca¡eine. Experimental proto-
cols were the same as those for Fig. 2. The amount of released
45Ca2 was obtained from the decrease in the 45Ca2 content in
HSR vesicles during 1 min after dilution. Each value was calcu-
lated by subtracting the amount of released 45Ca2 measured in
the presence of the test substance from that measured in its ab-
sence. F, MYTX; b, DIDS; E, ca¡eine. Values are means
þ S.E.M. (n = 3).
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induced Ca2 release, we studied Ca2 release from
HSR using representative inhibitors of Ca2 release
channels such as ryanodine (at WM), Mg2, procaine
and ruthenium red. 45Ca2 release triggered by DIDS
(10 WM), MYTX (1 WM) or ca¡eine (1 mM) was
completely inhibited by Mg2 in a concentration-de-
pendent manner with an IC50 value of approx. 250
WM (Fig. 5A). As shown in Fig. 5B, 45Ca2 release
stimulated by ca¡eine (1 mM) was potently inhibited
by procaine, whereas that stimulated by DIDS (10
WM) or MYTX (1 WM) was only partly inhibited.
The e¡ect of DIDS on the Ca2 release from HSR
was examined by monitoring extravesicular Ca2
concentration using Fluo-3 (Fig. 6). Upon the addi-
tion of 0.5 mM ATP, free Ca2 concentrations de-
creased gradually as a result of Ca2 uptake by Ca2
pump in HSR. When the concentration of Ca2 was
reduced to the steady state level, 0.5 WM MYTX, 10
WM DIDS or 1 mM ca¡eine was added. MYTX,
DIDS and ca¡eine caused marked Ca2 release
(Fig. 6A^C), which was blocked by pretreatment of
HSR with 5 WM ryanodine (Fig. 6C,D) or 2 WM
ruthenium red (Fig. 6F,G).
3.4. Interrelations of Ca2+ release mechanisms among
MYTX, DIDS and ca¡eine
Fig. 7 shows the interrelations of the 45Ca2 releas-
ing activities among MYTX, DIDS and ca¡eine. At
pCa 8, MYTX, DIDS and ca¡eine caused the max-
imum increase in 45Ca2 release at 10 WM, 30 WM
and 30 mM, respectively (Fig. 3). The maximum re-
sponse of 45Ca2 release induced by ca¡eine (30 mM)
was further increased in the presence of MYTX (10
WM) or DIDS (30 WM), whereas that induced by
DIDS (30 WM) was not a¡ected by MYTX (10 WM).
Fig. 5. E¡ects of Ca2 release channel inhibitors of 45Ca2 release on MYTX-, DIDS- and ca¡eine-induced 45Ca2 release from HSR.
Experimental protocols were the same as those for Fig. 3. Concentration-dependent e¡ects of Mg2 (A) and procaine (B) on 45Ca2
release induced by 1 WM MYTX, 10 WM DIDS and 1 mM ca¡eine were investigated. F, 1 WM MYTX; b, 10 WM DIDS; E, 1 mM
ca¡eine. Data are expressed as % of 45Ca2 release in the absence of inhibitors. Values are means þ S.E.M. (n = 3).
Fig. 4. E¡ect of free Ca2 concentrations on 45Ca2 release in-
duced by MYTX, DIDS and ca¡eine from HSR. Experimental
protocols were the same as those for Fig. 3. The amount of
45Ca2 released from HSR for 1 min after dilution into the me-
dium was obtained under several free Ca2 concentrations (pCa
8^3). a, control; F, 1 WM MYTX; b, 10 WM DIDS; E, 1 mM
ca¡eine. Values are means þ S.E.M. (n = 3).
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Fig. 7. Interrelations among the Ca2 releasing activities of MYTX, DIDS and ca¡eine. Experimental protocols were the same as
those for Fig. 3. The amount of 45Ca2 released from HSR for 1 min after dilution into the medium was obtained at pCa 8. The con-
centrations of ca¡eine (Ca¡), MYTX and DIDS were 30 mM, 10 WM and 30 WM, respectively. Values are means þ S.E.M. (n = 3).
*Signi¢cant (P6 0.01) di¡erence between the values.
Fig. 6. Typical recording traces of e¡ects of Ca2 release channel blockers on MYTX-, DIDS- and ca¡eine-induced Ca2 release mon-
itoring with a £uorescent Ca2 indicator. The extravesicular Ca2 concentration was monitored at 30‡C with a £uorescence spectro-
photometer. At the beginning of each experiment, 10 WM CaCl2 was added stepwise 5 times as the internal standard. The reaction of
Ca2 uptake was started by a simultaneous addition of 0.1 mg/ml creatine kinase (CK) and ATP after the addition of 0.75 mg/ml
HSR and 5 mM creatine phosphate (CP). In B^G, the traces are shown after the addition of CP. In D and E, ryanodine (Ry, 5 WM)
was treated for 3 min just before the addition of ATP. In F and G, ruthenium red (RR, 2 WM) was treated before the addition of
CP. A, ca¡eine (Ca¡, 1 mM); B, MYTX (0.5 WM) followed by ca¡eine (1 mM); C, DIDS (10 WM) followed by ca¡eine (1 mM); D,
MYTX (0.5 WM) followed by ca¡eine (1 mM) after addition of ryanodine (5 WM); E, DIDS (10 WM) followed by ca¡eine (1 mM)
after addition of ryanodine (5 WM); F, MYTX (0.5 WM) followed by ca¡eine (1 mM) after addition of ruthenium red (2 WM); G,
DIDS (10 WM) followed by ca¡eine (1 mM) after addition of ruthenium red (2 WM). The traces were representative in the prepara-
tions from three di¡erent animals.
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3.5. Common binding sites of the HSR proteins bound
to MYTX and DIDS
In order to determine whether MYTX and DIDS
had common binding sites, [3H]DIDS binding to
HSR was studied in the presence of MYTX. As
shown in Fig. 8, MYTX inhibited [3H]DIDS binding
to HSR in a concentration-dependent manner. Fur-
thermore, [125I]MYTX binding to 30 kDa protein on
PVDF membrane was studied in the presence of
DIDS. [125I]MYTX binding to 30 kDa protein was
inhibited by DIDS in a concentration-dependent
manner (Fig. 9), whereas that to CS, Ca2 pump
or 74 kDa protein was only slightly inhibited by it
(data not shown).
4. Discussion
Recently, it has been postulated that RyR, Ca2
release channel, is regulated by some intrinsic pro-
teins such as calsequestrin [7^9], triadin [10,36], junc-
tin [11,12] and 30 kDa protein [13,37,38] in the SR.
However, the detailed mechanism of the regulation
of RyR by intrinsic proteins remains to be solved.
Since [125I]MYTX did not bind to the puri¢ed RyR
[24] but MYTX-induced Ca2 release was abolished
by pretreatment with ryanodine (Fig. 6C) [25],
MYTX is assumed to bind to important regulatory
proteins of RyR. We found two new MYTX binding
proteins (30 and 74 kDa) other than Ca2 pump
[26,27] and CS [24] by binding of [125I]MYTX to
HSR proteins on the PVDF membrane after SDS-
PAGE. The 30 kDa protein was also a target protein
for [3H]DIDS.
DIDS, a stilbene derivative known as amino modi-
¢er and an anion exchanger blocker in red blood
cells [30], is shown to modulate the SR Ca2 channel
[14,30]. DIDS-induced Ca2 release from HSR was
not due to ionophoretic activity, because the rate of
Ca2 reuptake after a rapid Ca2 release was almost
the same as that before the addition of DIDS (Fig.
6C). DIDS-induced Ca2 release was blocked by rya-
nodine (at WM level) or ruthenium red, suggesting
that RyR is involved in the release (Fig. 6D^G).
The Ca2 dependence of DIDS-induced 45Ca2 re-
lease from HSR had a bell-shaped pro¢le which
was di¡erent from that of ca¡eine but similar to
that of MYTX (Fig. 3). Previously, we have shown
that the character of MYTX-induced Ca2 release
from HSR is resistant to procaine [22], indicating
its di¡erent characters from ca¡eine or adenine nu-
Fig. 9. Inhibition of [125I]MYTX binding to 30 kDa protein by
DIDS on PVDF membrane. Experimental protocols were the
same as those for Fig. 1. In A, the PVDF membrane was incu-
bated with [125I]MYTX (0.3 WM) in the presence of DIDS (0^3
WM) for 1 h at 0‡C after blocking with 1% BSA. In B, the date
are expressed as % of the density of [125I]MYTX binding to 30
kDa protein in the absence of DIDS.
Fig. 8. Concentration-dependent inhibition of [3H]DIDS bind-
ing by MYTX. HSR was incubated with 3 WM [3H]DIDS in
the presence of various concentrations of MYTX for 1 h at
0‡C, as described in Section 2. Nonspeci¢c binding was deter-
mined in the presence of 100 WM unlabeled DIDS. Values are
expressed as % of binding in the presence of 100 WM unlabeled
DIDS. Data are means þ S.E.M. (n = 3).
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cleotides [22,33]. Interestingly, DIDS-induced 45Ca2
release was also partially reduced by procaine, sug-
gesting again that the property of DIDS-induced
Ca2 release was di¡erent from that of ca¡eine but
similar to that of MYTX (Fig. 5).
Although MYTX and DIDS were powerful poten-
tiators of Ca2 release from HSR, the 45Ca2 release
induced by ca¡eine was further increased in the pres-
ence of MYTX or DIDS. However, DIDS-induced
45Ca2 release was not a¡ected in the presence of
MYTX. Therefore, it is suggested that MYTX and
DIDS, but not ca¡eine, have a common mechanism
in Ca2 release from HSR. In fact, [3H]DIDS bind-
ing to HSR was inhibited by MYTX (Fig. 8), and
[125I]MYTX binding to the 30 kDa protein on the
PVDF membrane was inhibited by DIDS in a con-
centration-dependent manner (Fig. 9). Thus, MYTX
and DIDS are assumed to commonly bind to 30 kDa
protein.
In conclusion, MYTX causes Ca2 release through
RyR with a mechanism common to DIDS. The tar-
get protein for the Ca2 releasing action of MYTX
may be 30 kDa protein, to which DIDS also binds.
MYTX is a useful probe for elucidating the func-
tional role of 30 kDa protein in excitation-contrac-
tion coupling of skeletal muscle.
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